Search Results for:
-
Other News To Note
Specifically, the partnership will focus on clinical trials to test combinations of immunotherapies, including two investigational drugs from Immune Design's pipelineBioWorld Today | Thursday, June 13, 2013 -
Clinic Roundup
The company recently launched the Crohn's disease clinical trial and is actively recruiting participants with moderate to severe diseaseBioWorld Today | Thursday, June 13, 2013 -
PRISM Banks $15M to Fund Cancer Drug R&D for Fibrosis
The compound is currently undergoing early stage clinical trials for the treatment of leukemia and solid tumor cancer, with rights to all oncology applications licensed to its partner, Eisai Co...And although full terms of the Series C funding round were not disclosed, they did include the hitting of milestones on the fibrosis clinical trial, according to PRISM Pharma CFO, Dai TakeharaBy Dave Silver | BioWorld Today | Thursday, June 13, 2013 -
Directed Evolution Gets Gene Therapy to Where it's Needed
Schaffer said that the criteria for what constitutes a new delivery method that warrants its own safety and biodistribution data "are currently being decided at the FDA level," but that the general assumption is that in the majority of cases, vectors produced by directed evolution will need their own dataset before they are admitted into clinical trialsBy Anette Breindl | BioWorld Today | Thursday, June 13, 2013 -
Taiwan's Biopharmaceutical Market Capitalization Soars
Significantly, the same NDA dossier was used in both submissions, a milestone in the path toward clinical trial regulatory harmonization, much sought after by both Taiwanese drugmakers and global pharmaceutical companies as an easier regulatory entryway into the enormous China market...P1101 is also undergoing clinical trials for treatment of polycythemia vera, a condition when the bone marrow makes too many red blood cells, leading to CV complications such as strokesBy Dave Silver | BioWorld International | Wednesday, June 12, 2013 -
U.S. Biopharma Firms Hit by Cyber Attacks from China
These efforts may have yielded valuable data from clinical trials or drug registration applicationsBy Shannon Ellis | BioWorld International | Wednesday, June 12, 2013 -
Other News To Note
Proceeds will be used to fund clinical trials, R&D for additional alpha-1 antitrypsin (AAT) indications, expanding distribution capabilities for additional territories for marketing AAT product Glassia and for general corporate purposesBioWorld International | Wednesday, June 12, 2013 -
Agios Files for $86M IPO to Support Cancer Trials
Agios expects to begin clinical trials by the middle of 2013 for its IDH2 candidate, AG-221, and in early 2014 for its IDH1 candidate, AG-120...Agios has said it may also be possible to use metabolites as biomarkers eventually for purposes such as identifying appropriate patients for clinical trialsBy Catherine Shaffer | BioWorld Today | Wednesday, June 12, 2013 -
Competition Shaping up in U.S. Biosimilars Game
The difficulty comes in the fact that, generally, patients enroll in a clinical trial in the hope of getting access to a new or improved therapy...Momenta, of Cambridge, Mass., would like to avoid the recruitment competition of large clinical trials in its development of up to six biosimilars partnered with Baxter International IncBy Mari Serebrov | BioWorld Today | Wednesday, June 12, 2013 -
Hitting the BRIC Wall? Report Examines Overseas Challenges
China, for example, has a plan "definitely" moving ahead to introduce a fast-track approval process for new drugs that could exclude firms that have not conducted clinical trials in the country, Das told BioWorld TodayBy Randy Osborne | BioWorld Today | Wednesday, June 12, 2013 -
With Immunotherapies, Patients May Live Though Tumors Grow
First published in 2000 by an international collaboration including the European Organization for Research and Treatment of Cancer, the National Cancer Institute and the National Cancer Institute of Canada Clinical Trials Group, and updated in 2009, the RECIST criteria are used in the majority of clinical trials. (See BioWorld Today, Jan. 27, 2009.) Bringing Progress RECIST clearly brought progress to cancer trials, not least by just introducing standardized criteria at allBy Anette Breindl | BioWorld Insight | Monday, June 10, 2013 -
U.S. Biopharma Firms Hit by Cyber Attacks from China
These efforts may have yielded valuable data from clinical trials or drug registration applicationsBy Shannon Ellis | BioWorld Today | Monday, June 10, 2013 -
AbbVie and Angels: Avaxia Closes $11M Series B for IBD
With data from the first clinical trial of anti-TNF polyclonal antibody AVX-470 in ulcerative colitis (UC) due toward the end of this year, Avaxia Biologics IncBy Jennifer Boggs | BioWorld Today | Monday, June 10, 2013 -
Financings Roundup
It will use the proceeds to identify clinical-stage drugs that might have activity against LAM and to begin clinical trialsBioWorld Today | Friday, June 7, 2013 -
The Future Is Now for EntreMed's China Strategy
As part of its development strategy to use its China resources, in January EntreMed submitted a new drug clinical trial application with the Chinese Food and Drug Administration (CFDA) for ENMD-2076 in triple-negative breast cancer...Patent Protection in China 'Essential' As a second prong to its China strategy, EntreMed is considering in-licensing compounds to build a portfolio of oncology drugs that can be moved through clinical trials and commercialized in ChinaBy Marie Powers | BioWorld Today | Friday, June 7, 2013 -
$0.00Audio Conferences | Thursday, June 6, 2013
-
Financings Roundup
Proceeds will be used to fund clinical trials, R&D for additional alpha-1 antitrypsin (AAT) indications, expanding distribution capabilities for additional territories for marketing AAT product Glassia and for general corporate purposesBioWorld Today | Thursday, June 6, 2013 -
Taiwan's Biopharmaceutical Market Capitalization Soars
Significantly, the same NDA dossier was used in both submissions, a milestone in the path toward clinical trial regulatory harmonization, much sought after by both Taiwanese drugmakers and global pharmaceutical companies as an easier regulatory entryway into the enormous China market...P1101 is also undergoing clinical trials for treatment of polycythemia vera, a condition when the bone marrow makes too many red blood cells, leading to CV complications such as strokesBy Dave Silver | BioWorld Today | Thursday, June 6, 2013 -
Morphosys, GSK Ink $586M Pact for MOR103 in RA, MS
Morphosys currently has more than 70 development programs under way, about 20 of which are undergoing clinical trialsBio Perspectives | Wednesday, June 5, 2013 -
Other News To Note
Nordic applied using a centralized procedure, with supporting data from clinical trials in more than 3,400 peopleBioWorld International | Wednesday, June 5, 2013
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9782)
- x BioWorld International (1967)
- x BioWorld Insight (1209)
- x Bio Perspectives (297)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
- x Upcoming (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.